Viewing Study NCT04523220


Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2025-12-26 @ 3:16 AM
Study NCT ID: NCT04523220
Status: COMPLETED
Last Update Posted: 2023-07-21
First Post: 2020-08-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis
Sponsor: Bayer
Organization: